|
|
||||||||
SHORT COMMUNICATION |
1 Colorado Division of Wildlife, Wildlife Research Center, 317 West Prospect Road, Fort Collins, Colorado 80526-2097, USA
2 Corresponding author (email: lisa.wolfe{at}state.co.us)
ABSTRACT:
Inadvertent ingestion of thiafentanil oxalate by a captive adult female mountain lion (Puma concolor) caused a prolonged clinical syndrome that included sedation and depression, muscle tension, and myopathy that was incompletely antagonized by naltrexone HCl. A serum chemistry profile revealed markedly elevated creatinine phosphokinase (CK; 490,450 IU/l), alanine aminotransferase (ALT; 1,896 IU/l), and aspartate aminotransferase (AST; 4,321 IU/l) 2 days after onset. The affected animals condition gradually improved over the next 15 days in response to supportive therapy that included diazepam (5 mg as needed), Normasol R® (3 l/day), dexamethasone (tapering dose starting at 1 mg/kg), and ketoprofen (1 mg/kg). She eventually recovered completely. Based on these observations, carcasses of animals immobilized with thiafentanil should be marked and disposed of properly to preclude opportunities for secondary exposure and potential intoxication in scavenging species. In addition, caution is advised when using thiafentanil in animals that could be preyed upon before full metabolism of the drug.
Key words: A3080, intoxication, mountain lion, opioid, puma, Puma concolor, secondary poisoning, thiafentanil.
This article has been cited by other articles:
![]() |
M. Cattet, G. Stenhouse, and T. Bollinger Exertional Myopathy in a Grizzly Bear (Ursus arctos) Captured by Leghold Snare J. Wildl. Dis., October 1, 2008; 44(4): 973 - 978. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |